{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T11:20:00Z","timestamp":1771845600995,"version":"3.50.1"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T00:00:00Z","timestamp":1539129600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2018.02445","type":"journal-article","created":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T04:24:14Z","timestamp":1539145454000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Pharmacokinetic\/Pharmacodynamic Integration to Evaluate the Changes in Susceptibility of Actinobacillus pleuropneumoniae After Repeated Administration of Danofloxacin"],"prefix":"10.3389","volume":"9","author":[{"given":"Longfei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihua","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zilong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinren","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangguang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huanzhong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2018,10,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/S1090-0233(02)00258-7","article-title":"Pharmacokinetics and PK-PD modelling of danofloxacin in camel serum and tissue cage fluids.","volume":"165","author":"Aliabadi","year":"","journal-title":"Vet. J."},{"key":"B2","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1128\/AAC.47.2.626-635.2003","article-title":"Pharmacokinetics (PK), Pharmacodynamics (PD), and PK-PD integration of danofloxacin in sheep biological fluids.","volume":"47","author":"Aliabadi","year":"","journal-title":"Antimicrob. Agents Chemother."},{"key":"B3","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0924-8579(00)00142-4","article-title":"Antibiotic treatment for animals: effect on bacterial population and dosage regimen optimisation.","volume":"14","author":"Aliabadi","year":"2000","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.2460\/ajvr.2001.62.1979","article-title":"Pharmacokinetics and pharmacodynamics of danofloxacin in serum and tissue fluids of goats following intravenous and intramuscular administration.","volume":"62","author":"Aliabadi","year":"2001","journal-title":"Am. J. Vet. Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/j.1365-3164.2009.00856.x","article-title":"New concepts in antimicrobial susceptibility testing: the mutant prevention concentration and mutant selection window approach.","volume":"20","author":"Blondeau","year":"2009","journal-title":"Vet. Dermatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.vetmic.2015.05.020","article-title":"Characterisation of a mobilisable plasmid conferring florfenicol and chloramphenicol resistance in Actinobacillus pleuropneumoniae.","volume":"178","author":"Boss\u00e9","year":"2015","journal-title":"Vet. Microbiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1089\/mdr.2005.11.248","article-title":"Resistance to fluoroquinolones linked to gyrA and parC mutations and overexpression of acrAB efflux pump in Salmonella enterica serotype Choleraesuis.","volume":"11","author":"Chu","year":"2005","journal-title":"Microb. Drug Resist."},{"key":"B8","first-page":"1","article-title":"\u201cPharmacodynamics of antimicrobials: general concepts and applications,\u201d","author":"Craig","year":"2001","journal-title":"Antimicrobial Pharmacodynamics in Theory and Clinical Practice"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1086\/508752","article-title":"The mutant selection window in rabbits infected with Staphylococcus aureus.","volume":"194","author":"Cui","year":"2006","journal-title":"J. Infect. Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1128\/AAC.47.5.1604-1613.2003","article-title":"In vitro pharmacodynamic evaluation of the mutant selection window hypothesis using four fluoroquinolones against Staphylococcus aureus.","volume":"47","author":"Firsov","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"B11","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.vetmic.2005.12.014","article-title":"Changes in antimicrobial susceptibility of Actinobacillus pleuropneumoniae isolated from pigs in Spain during the last decade.","volume":"115","author":"Guti\u00e9rrez-Mart\u00edn","year":"2006","journal-title":"Vet. Microbiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0924-8579(02)00025-0","article-title":"Rational dosing of antimicrobial drugs: animals versus humans.","volume":"19","author":"Lees","year":"2002","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1093\/jac\/dks195","article-title":"Evaluation of fluoroquinolone reduced dosage regimens in elderly patients by using pharmacokinetic modelling and Monte Carlo simulations.","volume":"67","author":"Leroy","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1128\/AAC.00975-10","article-title":"Mutant prevention concentration-based pharmacokinetic\/pharmacodynamic indices as dosing targets for suppressing the enrichment of levofloxacin-resistant subpopulations of Staphylococcus aureus.","volume":"55","author":"Liang","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"B15","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/jac\/dkg268","article-title":"Effect of chloramphenicol, erythromycin, moxifloxacin, penicillin and tetracycline concentration on the recovery of resistant mutants of Mycobacterium smegmatis and Staphylococcus aureus.","volume":"52","author":"Lu","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"B16","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.vetmic.2007.01.009","article-title":"Antimicrobial resistance profile of Actinobacillus pleuropneumoniae and Actinobacillus porcitonsillarum.","volume":"122","author":"Matter","year":"2007","journal-title":"Vet. Microbiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/jac\/dki079","article-title":"Standardization of pharmacokinetic\/pharmacodynamic (PK\/PD) terminology for anti-infective drugs: an update.","volume":"55","author":"Mouton","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"B18","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1001\/jama.279.2.125","article-title":"Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials.","volume":"279","author":"Preston","year":"1998","journal-title":"JAMA"},{"key":"B19","first-page":"1957","article-title":"Plasma pharmacokinetics of parenterally administered danofloxacin and enrofloxacin in pigs.","volume":"49","author":"Richez","year":"1997","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"B20","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1136\/vr.154.19.585","article-title":"Efficacy of danofloxacin in the treatment of respiratory disease in European cattle.","volume":"154","author":"Rowan","year":"2004","journal-title":"Vet. Rec."},{"key":"B21","first-page":"90","article-title":"Determination of optimum dosage schedules of danofloxacin following two extravascular routes of administration in buffalo calves (Bubalus bubalis).","volume":"19","author":"Sappal","year":"1996","journal-title":"Onl. J. Vet. Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.1128\/AAC.46.9.3013-3019.2002","article-title":"Pharmacokinetic and pharmacodynamic profiles of danofloxacin administered by two dosing regimens in calves infected with Mannheimia (Pasteurella) haemolytica.","volume":"46","author":"Sarasola","year":"2002","journal-title":"Antimicrobial. Agents Chemother."},{"key":"B23","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0034-5288(03)00005-5","article-title":"Pharmacokinetic-pharmacodynamic integration of danofloxacin in the calf.","volume":"74","author":"Shojaee","year":"2003","journal-title":"Res. Vet. Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3201\/eid0901.020172","article-title":"Dead bugs don\u2019t mutate: susceptibility issues in the emergence of bacterial resistance.","volume":"9","author":"Stratton","year":"2003","journal-title":"Emerg. Infect. Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0034-5288(02)00186-8","article-title":"Efficacy of danofloxacin 18% injectable solution in the treatment of Escherichia coli diarrhoea in young calves in Europe.","volume":"74","author":"Sunderland","year":"2003","journal-title":"Res. Vet. Sci."},{"key":"B26","doi-asserted-by":"crossref","first-page":"106","DOI":"10.54846\/jshap\/1002","article-title":"Antimicrobial susceptibility of Actinobacillus pleuropneumoniae, Pasteurella multocida, Streptococcus suis, and Bordetella bronchiseptica isolated from pigs in the United States and Canada, 2011 to 2015.","volume":"25","author":"Sweeney","year":"2017","journal-title":"J. Swine Health Prod."},{"key":"B27","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/j.1365-2885.2004.00613.x","article-title":"Integration and modelling of pharmacokinetic and pharmacodynamic data to optimize dosage regimens in veterinary medicine.","volume":"27","author":"Toutain","year":"2004","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"B28","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0034-5288(02)00039-5","article-title":"The pharmacokinetic\u2013pharmacodynamic approach to a rational dosage regimen for antibiotics.","volume":"73","author":"Toutain","year":"2002","journal-title":"Res. Vet. Sci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.vetmic.2009.09.067","article-title":"Molecular characterization of enrofloxacin resistant Actinobacillus pleuropneumoniae isolates.","volume":"142","author":"Wang","year":"2010","journal-title":"Vet. Microbiol."},{"key":"B30","author":"Watts","year":"2013","journal-title":"Performance Standards for Antimicrobial Disk and Dilution Susceptibilty Tests for Bacteria Isolated from Animals : Approved Standard"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.00874","article-title":"Relationship between cefquinome PK\/PD Parameters and emergence of resistance of Staphylococcus aureus in Rabbit tissue-cage infection model.","volume":"7","author":"Xiong","year":"2016","journal-title":"Front. Microbiol."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1186\/s12917-014-0297-1","article-title":"In vivo evaluation of mutant selection window of cefquinome against Escherichia coli in piglet tissue-cage model.","volume":"10","author":"Zhang","year":"","journal-title":"BMC Vet. Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.tvjl.2013.12.015","article-title":"Pharmacokinetics and ex vivo pharmacodynamics of cefquinome in porcine serum and tissue cage fluids.","volume":"199","author":"Zhang","year":"","journal-title":"Vet. J."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.00926","article-title":"The PK\u2013PD relationship and resistance development of danofloxacin against Mycoplasma gallisepticum in an In Vivo infection model.","volume":"8","author":"Zhang","year":"2017","journal-title":"Front. Microbiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"S147","DOI":"10.1086\/321841","article-title":"Restricting the selection of antibiotic-resistant mutants: a general strategy derived from fluoroquinolone studies.","volume":"33","author":"Zhao","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1086\/315708","article-title":"Selection of antibiotic-resistant bacterial mutants: allelic diversity among fluoroquinolone-resistant mutations.","volume":"182","author":"Zhou","year":"2000","journal-title":"J. Infect. Dis."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1093\/jac\/dks280","article-title":"Testing the mutant selection window in rabbits infected with methicillin-resistant Staphylococcus aureus exposed to vancomycin.","volume":"67","author":"Zhu","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"B38","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1093\/jac\/dkm542","article-title":"Selection of linezolid-resistant Enterococcus faecium in an in vitro dynamic model: protective effect of doxycycline.","volume":"61","author":"Zinner","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"B39","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1093\/jac\/dkg401","article-title":"Emergence of resistant Streptococcus pneumoniae in an in vitro dynamic model that simulates moxifloxacin concentrations inside and outside the mutant selection window: related changes in susceptibility, resistance frequency and bacterial killing.","volume":"52","author":"Zinner","year":"2003","journal-title":"J. Antimicrob. Chemother."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2018.02445\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T21:01:50Z","timestamp":1693947710000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2018.02445\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,10]]},"references-count":39,"alternative-id":["10.3389\/fmicb.2018.02445"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2018.02445","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,10]]},"article-number":"2445"}}